Cozens R - Search Results

1

The rate of killing of Escherichia coli by beta-lactam antibiotics is strictly proportional to the rate of bacterial growth.

Tuomanen E, Cozens R, Tosch W, Zak O, Tomasz A. Tuomanen E, et al. Among authors: cozens r. J Gen Microbiol. 1986 May;132(5):1297-304. doi: 10.1099/00221287-132-5-1297. J Gen Microbiol. 1986. PMID: 3534137

2

Evaluation of the bactericidal activity of beta-lactam antibiotics on slowly growing bacteria cultured in the chemostat.

Cozens RM, Tuomanen E, Tosch W, Zak O, Suter J, Tomasz A. Cozens RM, et al. Antimicrob Agents Chemother. 1986 May;29(5):797-802. doi: 10.1128/AAC.29.5.797. Antimicrob Agents Chemother. 1986. PMID: 3089141 Free PMC article.

3

Changes in peptidoglycan composition and penicillin-binding proteins in slowly growing Escherichia coli.

Tuomanen E, Cozens R. Tuomanen E, et al. Among authors: cozens r. J Bacteriol. 1987 Nov;169(11):5308-10. doi: 10.1128/jb.169.11.5308-5310.1987. J Bacteriol. 1987. PMID: 3312172 Free PMC article.

4

Role of autolysins in the activities of imipenem and CGP 31608, a novel penem, against slowly growing bacteria.

Cozens RM, Markiewicz Z, Tuomanen E. Cozens RM, et al. Antimicrob Agents Chemother. 1989 Oct;33(10):1819-21. doi: 10.1128/AAC.33.10.1819. Antimicrob Agents Chemother. 1989. PMID: 2574024 Free PMC article.

5

Penems: in vitro and in vivo experiments.

Zak O, Lang M, Cozens R, Konopka EA, Mett H, Schneider P, Tosch W, Scartazzini R. Zak O, et al. Among authors: cozens r. J Clin Pharmacol. 1988 Feb;28(2):128-35. doi: 10.1002/j.1552-4604.1988.tb05736.x. J Clin Pharmacol. 1988. PMID: 3283177 Review. No abstract available.

6

CGP 53437, an orally bioavailable inhibitor of human immunodeficiency virus type 1 protease with potent antiviral activity.

Alteri E, Bold G, Cozens R, Faessler A, Klimkait T, Lang M, Lazdins J, Poncioni B, Roesel JL, Schneider P, et al. Alteri E, et al. Among authors: cozens r. Antimicrob Agents Chemother. 1993 Oct;37(10):2087-92. doi: 10.1128/AAC.37.10.2087. Antimicrob Agents Chemother. 1993. PMID: 8257128 Free PMC article.

7

Large-scale purification and characterisation of a recombinant epidermal growth-factor receptor protein-tyrosine kinase. Modulation of activity by multiple factors.

McGlynn E, Becker M, Mett H, Reutener S, Cozens R, Lydon NB. McGlynn E, et al. Among authors: cozens r. Eur J Biochem. 1992 Jul 1;207(1):265-75. doi: 10.1111/j.1432-1033.1992.tb17047.x. Eur J Biochem. 1992. PMID: 1321046 Free article.

8

A potent protein-tyrosine kinase inhibitor which selectively blocks proliferation of epidermal growth factor receptor-expressing tumor cells in vitro and in vivo.

Lydon NB, Mett H, Mueller M, Becker M, Cozens RM, Stover D, Daniels D, Traxler P, Buchdunger E. Lydon NB, et al. Among authors: cozens rm. Int J Cancer. 1998 Mar 30;76(1):154-63. doi: 10.1002/(sici)1097-0215(19980330)76:1<154::aid-ijc24>3.0.co;2-b. Int J Cancer. 1998. PMID: 9533776 Free article. Retracted.

9

Aza-peptide analogs as potent human immunodeficiency virus type-1 protease inhibitors with oral bioavailability.

Fässler A, Bold G, Capraro HG, Cozens R, Mestan J, Poncioni B, Rösel J, Tintelnot-Blomley M, Lang M. Fässler A, et al. Among authors: cozens r. J Med Chem. 1996 Aug 2;39(16):3203-16. doi: 10.1021/jm960022p. J Med Chem. 1996. PMID: 8759643

10

Synthesis of potent and orally active HIV-protease inhibitors.

Capraro HG, Bold G, Fässler A, Cozens R, Klimkait T, Lazdins J, Mestan J, Poncioni B, Rösel JL, Stover D, Lang M. Capraro HG, et al. Among authors: cozens r. Arch Pharm (Weinheim). 1996 Jun;329(6):273-8. doi: 10.1002/ardp.19963290602. Arch Pharm (Weinheim). 1996. PMID: 8767110

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

37 results

Search Page